ScholarMate
English简体中文繁體中文
客服熱線:400-1616-289
登入註冊
期刊論文

Effect of mesenchymal-epithelial transition amplification on immune microenvironment and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer

Su, Shan; Lin, Anqi; Luo, Peng; Zou, Jianjun; Huang, Zhihao; Wang, Xiaojun; Zeng, Yunyun; Cen, Wenchang; Zhang, Xianlan; Huang, Huiyi; Hu, Jinxing*; Zhang, Jian*南方医科大学
Annals of Translational Medicine2021-9DOI: 10.21037/atm-21-4543
3被引7閱讀
引用收藏
分享

摘要

Background: Immune checkpoint inhibitors (ICIs) have brought clinical benefits to patients with various histological types of lung cancer. Previous studies have shown an association between mesenchymal-epithelial transition (MET) and the immunotherapy response in non-small cell lung cancer (NSCLC) but there is a lack of clinical data on the correlation of MET amplification with the ICI response in NSCLC. @@@ Methods: Copy number alteration (CNA), somatic mutation, and clinical data from two immunotherapy cohorts (Rizvi et al. cohort and our local cohort) were collected and pooled to further investigate the key role of MET amplification in patients with NSCLC receiving ICIs. The correlations between MET amplification and tumor immunogenicity and antitumor immunity were further investigated in The Cancer Genome Atlas (TCGA)-NSCLC [lung adenocarcinoma (LUAD)/lung squamous cell carcinoma (LUSC)] data-set. @@@ Results: In the immunotherapy cohorts, MET amplification was associated with longer progression-free survival (PFS) times in patients receiving ICI treatment (P=0.039; HR=0.37; 95% CI: 0.18-0.73). In the TCGA-NSCLC data-set, MET amplification was associated with high MET mRNA and protein levels, tumor mutation burden (TMB), neoantigen load (NAL), immune-activated cell patterns, immune-related gene expression levels, and the number of gene alterations in the DNA damage response and repair (DDR) pathway. Gene set enrichment analysis (GSEA) results indicated significant up-regulation of the immune response-related pathways in the MET-amplification group. @@@ Conclusions: Our results suggest that MET amplification may be a novel predictive marker for immunotherapy efficacy in NSCLC.

學科與關鍵詞

關鍵詞
Mesenchymal-epithelial transition amplification (MET amplification)immunotherapyimmune microenvironmentimmune checkpoint inhibitors (ICIs)non-small cell lung cancer (NSCLC)
相關
載入中…
  • MET Amplification and Immune Checkpoint Inhibitor Efficacy in NSCLC
    Su, S.; Luo, P.; Zhang, J.; Zhang, B.; Zou, J.; Huang, Z.被引 1
  • TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Lin, Anqi; Zhang, Hongman; Meng, Hui; Deng, Ze; Gu, Tianqi; Luo, Peng*; Zhang, Jian*Frontiers in Immunology, 2021, 12: 667875.被引 8
  • MGA Mutation as a Novel Biomarker for Immune Checkpoint Therapies in Non-Squamous Non-Small Cell Lung Cancer
    Sun, Lei; Li, Man; Deng, Ling; Niu, Yuchun; Tang, Yichun; Wang, Yu*; Guo, Linlang*Frontiers in Pharmacology, 2021, 12: 625593.被引 5
查看全部 →

發表資訊

論文狀態
公開發表
期刊
Annals of Translational Medicine
發表日期
2021-09
卷期
第 9 卷, 第 18 期
頁碼
1475
DOI
10.21037/atm-21-4543
期刊收錄
NSL
期刊等級
3区
成果收錄
SCIE
資助標註
National Natural Science Foundation of China [82003304]; Guangzhou Science and Technology Program, China [202102080013]

作者

  • S

    Su, Shan (第一作者)

    guangzhou chest hosp

  • L

    Lin, Anqi

    southern med univ

查看全部 12 位作者收起作者
  • L

    Luo, Peng

    southern med univ

  • Z

    Zou, Jianjun

    guangzhou chest hosp

  • H

    Huang, Zhihao

    guangzhou chest hosp

  • W

    Wang, Xiaojun

    first peoples hosp chenzhou

  • Z

    Zeng, Yunyun

    guangzhou chest hosp

  • C

    Cen, Wenchang

    guangzhou chest hosp

  • Z

    Zhang, Xianlan

    guangzhou chest hosp

  • H

    Huang, Huiyi

    guangzhou chest hosp

  • H

    Hu, Jinxing (通訊)

    guangzhou chest hosp

  • Z

    Zhang, Jian (通訊)

    southern med univ

登入解鎖更多功能

  • 收藏這篇,隨時在「我的 · 收藏」找回
  • 認領你的成果,生成推廣素材
  • 關注作者獲取最新成果
  • 加入項目組、協同寫作
註冊 / 登入

產品服務

  • 科研之友
  • 創新城
  • 科創雲

服務支援

  • 幫助中心
  • 隱私政策
  • 服務條款

聯絡方式

線上客服:【】
客服熱線:400-1616-289
電子郵件:support@scholarmate.com

關注或下載科研之友

微信 QR Code
微信公眾號
客戶端下載 QR Code
下載客戶端
科研成果科研人員科研機構科研動態愛瑞思軟件

©2026 深圳市科研之友网络服务有限公司

公安備案圖示粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417